The global Pancreatic Cancer Therapeutics and Diagnostics market was valued at 2758 million in 2024 and is projected to reach US$ 3936 million by 2031, at a CAGR of 5.2% during the forecast period.

The global Allied Health Care market was valued at 32100 million in 2024 and is projected to reach US$ 49668 million by 2031, at a CAGR of 6.7% during the forecast period.

The global Genome Editing Enzymes market was valued at 395 million in 2024 and is projected to reach US$ 573 million by 2031, at a CAGR of 5.5% during the forecast period.

The global Genome Editing Tool Enzymes market was valued at 395 million in 2024 and is projected to reach US$ 573 million by 2031, at a CAGR of 5.5% during the forecast period.

The global Toxicological Risk Assessments (TRA) market was valued at 5496 million in 2024 and is projected to reach US$ 12197 million by 2031, at a CAGR of 10.7% during the forecast period.

The global Cord Blood and Tissue Banking market was valued at 1826 million in 2024 and is projected to reach US$ 2954 million by 2031, at a CAGR of 7.4% during the forecast period.

The global Thyroid Function Health Test market was valued at 1246 million in 2024 and is projected to reach US$ 1881 million by 2031, at a CAGR of 5.6% during the forecast period.

The global Nanobody Humanization Service market was valued at 97 million in 2024 and is projected to reach US$ 141 million by 2031, at a CAGR of 5.7% during the forecast period.

The global Nanobody Sequencing Service market was valued at 124 million in 2024 and is projected to reach US$ 178 million by 2031, at a CAGR of 5.4% during the forecast period.

The global Immune Function Evaluations market was valued at 3475 million in 2024 and is projected to reach US$ 10214 million by 2031, at a CAGR of 14.4% during the forecast period.